Most Popular
-
1
1 in 3 Koreans live alone, family types becoming diverse
-
2
Korea, Japan finance chiefs vow to tame rampant FX market volatility
-
3
US 'incredibly concerned' about suspected NK-Iran military ties
-
4
K-pop group's manager dismissed for setting up spycam in theater dressing room
-
5
K-pop singer lost consciousness after being hit by foul ball, cancels show
-
6
Korean Muslim YouTuber's plan to build mosque in Incheon goes viral
-
7
Contentious grain bill put directly to plenary meeting for vote
-
8
Why is Apple Pay struggling to get purchase in Korea?
-
9
Yoon's office denies considering liberal figures for key posts
-
10
Seoul says Fu Bao loan 'not going to happen'
PM orders full review of EMA's findings before resuming use of AstraZeneca's vaccine
By YonhapPublished : April 8, 2021 - 11:53
Prime Minister Chung Sye-kyun on Thursday ordered health authorities to thoroughly and swiftly review the latest findings by the European Medicines Agency (EMA) on the safety of AstraZeneca's vaccine.
The Korea Disease Control and Prevention Agency should "swiftly reach a scientific conclusion on the findings and share the results with the public in a transparent manner," he said.
While rare blood clots have been reported among people administered with the vaccine, the EMA said "the benefits (of administering the vaccine) outweigh the risks," he added.
On Wednesday, the country suspended the use of AstraZeneca's vaccine for people under age 60, special education instructors and school nurses to "prioritize people's health and safety." Later that day, the EMA announced there is a "possible link" between the vaccine and unusual blood clot cases.
The government will decide on resuming use of AstraZeneca's vaccine for the group after closely analyzing the EMA's findings, Chung said.
"We will focus on devising effective antivirus measures as the country is at risk of entering a fourth wave of infections," he said. (Yonhap)
The Korea Disease Control and Prevention Agency should "swiftly reach a scientific conclusion on the findings and share the results with the public in a transparent manner," he said.
While rare blood clots have been reported among people administered with the vaccine, the EMA said "the benefits (of administering the vaccine) outweigh the risks," he added.
On Wednesday, the country suspended the use of AstraZeneca's vaccine for people under age 60, special education instructors and school nurses to "prioritize people's health and safety." Later that day, the EMA announced there is a "possible link" between the vaccine and unusual blood clot cases.
The government will decide on resuming use of AstraZeneca's vaccine for the group after closely analyzing the EMA's findings, Chung said.
"We will focus on devising effective antivirus measures as the country is at risk of entering a fourth wave of infections," he said. (Yonhap)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240418181020)
![[Today’s K-pop] Zico drops snippet of collaboration with Jennie](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/18/20240418050702_0.jpg&u=)